ORICORIC Pharmaceuticals, Inc.
$12.02-15% 1Y
$12.02
$7.4752 weeks$14.67
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +10% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ORIC is trading
ORIC Pharmaceuticals, Inc. is −15% over the past year while the S&P 500 is +18%: 33 points behind the market.
−15%
1-year return · S&P 500 +18%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-10-08
- $12.02
- 1 monthS&P 500 +1.6%
- −3.7%
- 1 yearS&P 500 +18%
- −15%
- 5 yearsS&P 500 +86%
- −43%
- vs 50-day average$12.98
- −7.4%
- 52-week high
- $14.67
- 52-week low
- $7.47
- Annualised volatility
- 84%
| Year | Return |
|---|---|
| 2026 (year to date) | +47% |
| 2025 | +1.4% |
| 2024 | −12% |
| 2023 | +56% |
| 2022 | −60% |
| 2021 | −57% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +4.0% |
| Feb | 6 | 3 of 6 | −1.4% |
| Mar | 6 | 2 of 6 | −9.2% |
| Apr | 6 | 1 of 6 | −17% |
| May | 7 | 4 of 7 | +4.7% |
| Jun | 7 | 5 of 7 | +16% |
| Jul | 7 | 3 of 7 | +0.23% |
| Aug | 7 | 5 of 7 | +10% |
| Sep | 7 | 2 of 7 | −3.7% |
| Oct | 7 | 2 of 7 | −8.5% |
| Nov | 6 | 4 of 6 | +17% |
| Dec | 6 | 3 of 6 | +6.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.